Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age
Clinical trial NCT02576639 · COMPLETED
Trial details
- NCT number
- NCT02576639
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-10
- Primary completion
- 2016-03-11
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.